Dad’s aggressive brain cancer vanishes after taking new drug
Scientists have identified a "hidden vulnerability" in glioblastoma, an aggressive form of brain cancer, suggesting a specialised diet could slow tumour growth.
Groundbreaking research indicates that combining a prescribed diet with steroid anti-inflammatory drugs could significantly impact glioblastoma progression.
The study, published in Science Advances, involved an international team including researchers from the Cancer Research UK Scotland Institute.
It revealed that steroid medications dramatically alter how glioblastoma cells process vitamin B3, creating a metabolic weakness.
Exploiting this weakness, reducing the amino acid methionine in a patient’s diet while on steroids effectively starves glioblastoma cells, slowing tumour growth in preclinical models.
Bookmark popover
Removed from bookmarks